DigestRedComo funciona
Red
/
Empresas
Se
No verificado

SetPoint Medical

Sobre qué escribimos

BiotecnologíaEventosIndustriaMaterial médico sanitarioSalud

11 Comunicados de prensa

Ver todos los comunicados de prensa
25/11/2025
Material médico sanitario
Higiene alimentaria
Salud
Biotecnología
Eventos
Ferias y Congresos
SetPoint Medical to Present at Piper Sandler 37th Annual Healthcare Conference
Fuente
SetPoint Medical
Editor
Business Wire
1.00
0
24/11/2025
Industria
Biotecnología
Salud
Medicina - Varios
Material médico sanitario
SetPoint Medical Announces CMS Transitional Pass-Through Payment Approval for the SetPoint System, the Breakthrough Neuroimmune Modulation Platform
Fuente
SetPoint Medical
Editor
Business Wire
1.00
0
25/10/2025
Eventos
Industria
Ciencia
Medicina nuclear
Biotecnología
Sanidad
Salud
Material médico sanitario
SetPoint Medical to Present Data at ACR Convergence 2025 Demonstrating Sustained Efficacy and Safety for the SetPoint System to Treat Rheumatoid Arthritis
Fuente
SetPoint Medical
Editor
Business Wire
1.00
0
11/08/2025
Biotecnología
Salud
Material médico sanitario
SetPoint Medical Raises $140 Million in Private Financing and Expands Leadership Team to Support Commercialization of Rheumatoid Arthritis Therapy
Fuente
SetPoint Medical
Editor
Business Wire
1.00
0
31/07/2025
SetPoint Medical Receives FDA Approval for Novel Neuroimmune Modulation Therapy for Rheumatoid Arthritis
Fuente
SetPoint Medical
Editor
Business Wire
1.00
0
11/06/2025
Sanidad
Salud
Ciencia
Medicina - Varios
Eventos
Industria
SetPoint Medical Receives Clinical Research Award at EULAR 2025 Congress
Fuente
SetPoint Medical
Editor
Business Wire
1.00
0
04/06/2025
Mercado laboral
Material médico sanitario
Salud
VIH, SIDA y enfermedades autoinmunes
Sanidad
Farmacéutica
SetPoint Medical Appoints Tyler Binney to Its Board of Directors
Fuente
SetPoint Medical
Editor
Business Wire
1.00
0
09/12/2024
Industria
Biotecnología
Higiene alimentaria
Salud
Material médico sanitario
SetPoint Medical Announces Filing of Premarket Approval (PMA) Application to the U.S. Food and Drug Administration (FDA) for Novel Neuroimmune Modulation Device for the Treatment of Rheumatoid Arthritis
Fuente
SetPoint Medical
Editor
Business Wire
1.00
0
18/11/2024
SetPoint Medical Announces Late-Breaking Data from RESET-RA Study at ACR Convergence 2024
Fuente
SetPoint Medical
Editor
Business Wire
1.00
0
02/10/2024
Industria
Ciencia
Material médico sanitario
Higiene alimentaria
Medicina - Varios
Salud
Ir de compras
SetPoint Medical Receives FDA’s IDE Approval for U.S. Pilot Study of Neuroimmune Modulation Platform in Adults with Relapsing-Remitting Multiple Sclerosis
Fuente
SetPoint Medical
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0